Biological [clinicaltrials_vocabulary:Biological]
Monovalent OPV 4 week interval [clinicaltrials_resource:000212b33daee2e34d47e1afbfaf8f84]GINI [clinicaltrials_resource:000394ecaedce51bce4541528ad47058]GlaxoSmithKline Biologicals' Influsplit SSW®/Fluarix™ 2002/2003 [clinicaltrials_resource:00094f99bdd5bf084b573ef43c414692]Trichuris trichiura eggs [clinicaltrials_resource:001193ce54f6717085bb9c6d502785e3]FMT infusions [clinicaltrials_resource:00164b0fa23bb600c67e3efaedb77714]blood sampling [clinicaltrials_resource:001d3dfe99dd50250a7061eeac44da4b]ALV003 placebo [clinicaltrials_resource:001ea4a49696b17ed57103d94494b422]Hematopoietic stem cell transplantation [clinicaltrials_resource:00248a7f2f05a25e61c2e2c27d0d57d7]trastuzumab [clinicaltrials_resource:00291e36a9aa0522449eda6cdeb9bcf0]T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens [clinicaltrials_resource:002ef49ceaf4207e3a0d27137d7af3b4]Swine A/H1N1 influenza vaccine (split virion, inactivated) [clinicaltrials_resource:0030bf0a2ed2a29c890ecc268c7bceb6]cAd3-EBO [clinicaltrials_resource:0034b8ec11b5d70bb4690da63f4a397d]Tetanus Toxoid Vaccine [clinicaltrials_resource:00356fb6a57c1c9ac0beb49ca9bc4a35]IL-YANG Flu Vaccine TIV 0.5mL [clinicaltrials_resource:003673434421183d680cc5ccbef60969]ACC-001 3 μg/ QS-21 50 μg [clinicaltrials_resource:00376e207950d5062dbd59661625aa0d]1 dose Varicella vaccine and 1 dose MMR given at the same time [clinicaltrials_resource:0038dca5997d1a3802e642ebb5198fcb]Monovalent Frozen FluMist® [clinicaltrials_resource:003da5bba3c8c6861954025a7b9a1e1d]Baminercept alfa [clinicaltrials_resource:003e4235436c72753718cb5ac9c655b9]adalimumab (HUMIRA®) [clinicaltrials_resource:00412a0337593c304b3e8ca2a934e97c]carboxylesterase-expressing allogeneic neural stem cells [clinicaltrials_resource:0041f7fcc7aeba217cc149c5ea4fef59]RI-001 [clinicaltrials_resource:0041fb6399f493d0b9a55c8ddf92e833]Salmonella Typhi-vectored pneumonia vaccine [clinicaltrials_resource:004534a6182b8c57068e8f915b2cbf22]CTB by nasal way [clinicaltrials_resource:00499a3b3e3f0b1e6fc6156990d94dd4]peginterferon alfa-2a [clinicaltrials_resource:0049e52b124bf5a21bafc026470ba6da]Gardasil™ [clinicaltrials_resource:004e3ede3648596d271c56175f3b60c8]Pediarix® [clinicaltrials_resource:00506ae31f8baa35e68ac15e7ced9e77]Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads [clinicaltrials_resource:00516d0d32e8b999d7b850541b7f42e8]GSK investigational vaccine GSK2340269A [clinicaltrials_resource:0051ba404a9ef2ed5b29f3ce4bdda16a]Japanese encephalitis vaccine [clinicaltrials_resource:0053ee7c4b9bcdcbb282448e49da8a84]Pneumo 23 [clinicaltrials_resource:00565500fba1258f120d84c1329151b1]Placebo [clinicaltrials_resource:0057a3245bad92f242d8b0f7d09146ae]TIL infusion [clinicaltrials_resource:00584ef0ee4e3e1139bacbd00b0de432]Trivalent inactivated influenza vaccine [clinicaltrials_resource:005a63f9e6b17a225d7b9e9a892e20e9]JVS-100 15 mg dose Injection [clinicaltrials_resource:005b68d8b1cd7312f9c3ff3f2ffe46ee]filgrastim [clinicaltrials_resource:005dacd29b9f3b61bf42c90fc4b44a08]Live Attenuated Varicella Vaccine [clinicaltrials_resource:005e09affec2398b362d729f7d91f779]Rituximab [clinicaltrials_resource:0062784aecb5d0224fc2fb6bd36ea461]infliximab [clinicaltrials_resource:006325e0d32bdf74cc2ce628a273db5c]OSA [clinicaltrials_resource:00660d12680ea9eb93184c8566f93924]MEDI-524 (Numax-TM) [clinicaltrials_resource:006871c3a6cb6c4fdb768ce4125ee9e5]
type
Biological [clinicaltrials_vocabulary:Biological]
Bio2RDF identifier
Biological
Bio2RDF namespace
clinicaltrials_vocabulary
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_vocabulary:Biological
identifier
clinicaltrials_vocabulary:Biological
title
Biological
@en
label
Biological [clinicaltrials_vocabulary:Biological]
@en